Dr. Thomas E. Stinchcombe
Overview
I am a part of the thoracic oncology program. I work with patients who have cancers of the lung, which includes non-small cell lung cancer, small cell lung cancer, and mesothelioma. My focus is on clinical care, clinical trials, and developing new therapies for these diseases. When I first meet with a patient, I want them to understand what their diagnosis is, because there are actually multiple diagnoses of lung cancer and each are treated differently. Then I discuss with a patient whether they are a candidate for therapies such as molecular therapy or immunotherapy, and make sure they have a clear understanding of the treatment plan. There are some very promising new therapies for these diseases and we are fortunate to have those available to patients here at Duke. That’s one of the unique things we offer as an academic medical center.
Dr. Stinchcombe is highly rated in 13 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Gamma Knife Radiosurgery.
His clinical research consists of co-authoring 178 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- MEDICARE MAPD
- MEDICARE SNP
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
20 Duke Medicine Cir, Durham, NC 27710
Additional Areas of Focus
Dr. Stinchcombe has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
8 Clinical Trials
Duke Cancer Center
Diane Reidy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Reidy is highly rated in 18 conditions, according to our data. Her top areas of expertise are Neuroendocrine Tumor, Pancreatic Islet Cell Tumor, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization.
Duke Cancer Center
When someone is faced with a diagnosis of lung cancer, they may be going through surgery, radiation treatment, chemotherapy or enrolling in a clinical trial. It’s a very complicated process to understand what’s involved and what may happen next. It’s also hard to hear all the answers if you’re by yourself. We encourage our patients to come with family members and friends and loved ones and particularly to identify one or two main go-to people in terms of care-giving and support. That way we can engage them in the whole process. Just as we have a team taking care of the patient, the patient has a team, too. At Duke, we have the opportunity to engage patients in the very latest treatment approaches, whether it’s a new surgical technique, the latest radiation approach, or some novel chemotherapy, immunology, or targeted therapy, several of which we’ve been developing. Duke provides patients with a real opportunity that they may not have elsewhere. Dr. Crawford is highly rated in 23 conditions, according to our data. His top areas of expertise are ALK-Positive Non-Small Cell Lung Cancer, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, and Small Cell Lung Cancer (SCLC).
Duke Cancer Center
I am a medical oncologist who focuses on bone and soft tissue cancers called sarcomas. I love spending time with my patients. They often have a sense of awareness about their condition that’s truly unique and rewarding. I partner with each patient so they know the full set of options available for treatment and can make an informed decision about the approach that is best for them. I’ve wanted to pursue medicine for as long as I can remember. I find cancer fascinating because of its ability to evade the immune system. The body fails to recognize cancer as being foreign. When I am not at work, I love spending time with my family and enjoy long distance running. Dr. Riedel is highly rated in 30 conditions, according to our data. His top areas of expertise are Adult Soft Tissue Sarcoma, Liposarcoma, Desmoid Tumor, and Angiosarcoma.
Frequently Asked Questions about Dr. Thomas E. Stinchcombe
How do I make an appointment with Dr. Thomas E. Stinchcombe?
You can book an appointment with Dr. Thomas E. Stinchcombe by calling their office at 919-681-6900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Thomas E. Stinchcombe a top-rated expert for Non-Small Cell Lung Cancer (NSCLC)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Thomas E. Stinchcombe is classified as an Elite expert for Non-Small Cell Lung Cancer (NSCLC), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Thomas E. Stinchcombe specialize in?
While Dr. Thomas E. Stinchcombe is a Oncology, they have specific expertise in Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and Small Cell Lung Cancer (SCLC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Thomas E. Stinchcombe participate in research or clinical trials?
Yes. Dr. Thomas E. Stinchcombe has published 178 articles and abstracts on conditions like Non-Small Cell Lung Cancer (NSCLC). You can view a list of Dr. Thomas E. Stinchcombe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Thomas E. Stinchcombe accept my insurance?
Dr. Thomas E. Stinchcombe accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 919-681-6900 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Stinchcombe isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Dr. Stinchcombe isElite. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Small Cell Lung Cancer (SCLC)Dr. Stinchcombe isElite. Learn about Small Cell Lung Cancer (SCLC).
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Stinchcombe isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Stinchcombe isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Stinchcombe isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Stinchcombe isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Stinchcombe isDistinguished. Learn about Pleuropulmonary Blastoma.
- Squamous Cell Lung CarcinomaDr. Stinchcombe isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- MesotheliomaDr. Stinchcombe isAdvanced. Learn about Mesothelioma.
- Metastatic Pleural TumorDr. Stinchcombe isAdvanced. Learn about Metastatic Pleural Tumor.
- Posterior Fossa TumorDr. Stinchcombe isAdvanced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)Dr. Stinchcombe isAdvanced. Learn about Primitive Neuroectodermal Tumor (PNET).
- Experienced
- Adult Soft Tissue SarcomaDr. Stinchcombe isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Stinchcombe isExperienced. Learn about Agranulocytosis.
- Anal CancerDr. Stinchcombe isExperienced. Learn about Anal Cancer.
- Bone TumorDr. Stinchcombe isExperienced. Learn about Bone Tumor.
- Colorectal CancerDr. Stinchcombe isExperienced. Learn about Colorectal Cancer.
- Endometrial Stromal SarcomaDr. Stinchcombe isExperienced. Learn about Endometrial Stromal Sarcoma.